FDA Clears Lilly’s Foundayo Pill
WASHINGTON — Federal health regulators approved Eli Lilly’s oral obesity medicine Foundayo (orforglipron), creating a new daily pill option in the fast-growing GLP-1 market, according to U.S. Food and Drug…
FDA Approves Higher-Dose Wegovy HD for Weight Loss
Washington, D.C. — The U.S. Food and Drug Administration on Thursday approved a new higher-dose version of the blockbuster obesity drug Wegovy, offering patients the potential for greater weight loss…
Novo Nordisk cuts Ozempic, Wegovy prices
COPENHAGEN, Feb. 24 – Novo Nordisk said it will cut U.S. list prices for its blockbuster weight-loss drug Wegovy and diabetes treatment Ozempic effective Jan. 1, 2027, lowering the monthly…
FDA flags Novo Wegovy pill ad
WASHINGTON — The Food and Drug Administration said a television advertisement for Novo Nordisk’s Wegovy weight‑loss pill is “false or misleading,” citing an agency letter dated Feb. 5 that flagged…